Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Leukaemia

Pathology Hematology and hematologic malignancies

Ronald Hoffman

Myeloproliferative Disorders (MPD) Research Consortium

Leukaemia

Pathology Hematology and hematologic malignancies

Denis Lacombe

EORTC Headquarters

Leukaemia

Paola Friedrich-Medina

Pediatric Oncology Twinning Program

Sarcoma Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Pediatric oncology or childhood cancer

Investigator from BioInvent (Sweden)

Clinical validation of the CD32b biomarker on the European market

Leukaemia

Pathology

Jeffrey S Miller

Viral priming and targeting NK cells against solid tumor malignancies

Leukaemia

Hematology and hematologic malignancies

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Martine Extermann

Decision Models to Compare Treatments in Older Patients with AML

Leukaemia

Hematology and hematologic malignancies